Gene PACS2 (associated with AD developmental and epileptic encephalopathy 66, OMIM 618,067) was most frequently altered (seven individuals harboring rare highly deleterious heterozygous SNV) (Supplementary Table 2). This evidence concerns the gene PACS2 and Alzheimer disease.